SCHEMBL7092243

SCHEMBL7092243

O=C(O)c1oc2ccccc2c(=O)c1Br

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 5/20 0.52
KDM4E B2RXH2 3/20 0.52
CYP3A4 P08684 3/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
MAPT P10636 2/20 0.52
ALDH1A1 P00352 2/20 0.52
HPGD P15428 2/20 0.52
HSD17B10 Q99714 2/20 0.52
GLA P06280 1/20 0.52
PGAM1 P18669 1/20 0.52
CASP1 P29466 1/20 0.52
CASP7 P55210 1/20 0.52
TTR P02766 4/20 0.51
KMT2A Q03164 3/20 0.50
MEN1 O00255 2/20 0.50
ALOX15 P16050 2/20 0.50
MAPK1 P28482 2/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1893714 0.87 KMT2A (0.49) KDM4ESMN1; SMN2MAPTALDH1A1HPGD
SCHEMBL752884 0.81 KDM4E (0.65) MAOAKDM4ECYP3A4SMN1; SMN2MAPT
SCHEMBL11360558 0.81 KDM4E (0.53) MAOAKDM4ECYP3A4SMN1; SMN2MAPT
SCHEMBL6045428 0.79 TTR (0.52) MAOAKDM4ECYP3A4SMN1; SMN2MAPT
SCHEMBL29587413 0.79 TTR (0.52) MAOAKDM4ECYP3A4SMN1; SMN2MAPT
SCHEMBL15820941 0.78 TTR (0.50) MAOAKDM4ECYP3A4SMN1; SMN2MAPT
SCHEMBL3417705 0.78 CA1 (0.61) MAOAKDM4ECYP3A4SMN1; SMN2MAPT
SCHEMBL15820937 0.78 TTR (0.50) MAOAKDM4ECYP3A4SMN1; SMN2MAPT
SCHEMBL29591307 0.78 CA1 (0.61) MAOAKDM4ECYP3A4SMN1; SMN2MAPT
SCHEMBL5972191 0.78 MEN1 (0.49) KDM4ECYP3A4SMN1; SMN2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1353915-A2 THERAPEUTIC CHROMAN COMPOUNDS AstraZeneca AB (SE) 2003-10-22 EP disclosed
WO-2002055014-A2 THERAPEUTIC CHROMAN COMPOUNDS ASTRAZENECA AB (SE) 2002-07-18 WO disclosed